{"domain":"molecularpartners.com","status":"valid","tier":"listed","authority":47,"verified":false,"title":"Molecular Partners: Building tomorrow’s breakthroughs","summary":"Molecular Partners develops DARPin therapeutics for cancer and serious diseases through innovative oncology and radiopharmaceutical programs\\.","country":"FR","country_source":"ip","llms_txt":"https://www.molecularpartners.com/llms.txt","llms_full_txt":null,"last_checked":"2026-10-21T09:32:42.173Z","agent_terms":null,"categories":["healthcare","science-research"],"capabilities":[],"inferred_tags":["darpin therapeutics","oncology","radiopharmaceuticals","biotech","cancer drug development"],"audience":"mixed","agent_uses":["search_content"],"language":"en","platform_generated":false,"agent_summary":"Molecular Partners: biotech developing DARPin therapeutics for cancer, with oncology and radiopharmaceutical programs, science pages, scientific board and caree","llms_txt_cached":"https://agentwebmap.com/v1/domain/molecularpartners.com/llms.txt","agentic":"informational","section_keys":["optional","pages","scientific-board-members"],"section_partial":false,"section_indexed_at":"2026-10-21T14:16:17.559Z"}